COVID-19 RESPONSE

For your safety and per Public Order, mask wearing is MANDATORY for entrance into our hospital and clinics. Learn More

Current Clinical Trials

What Are Clinical Trials?

Clinical trials are a type of clinical research in which patients can volunteer to participate. Clinical trials try to find better and new ways to prevent, detect or treat diseases. Clinical research is an integral part of the mission of the Christus St. Vincent Cancer Center. We believe in offering access to clinical trials for our patients close to home, giving our patients access to the latest therapies here in New Mexico.

Below is a current list of clinical trials being offered at the Christus St. Vincent Regional Cancer Center.


2455-002

An Open-label, Phase I Study of KHK2455 in Combination with Avelumab in Adult Subject with Locally Advanced or Metastatic Urothelial Carcinoma


DS1062-A-U102

Phase 1b, Open-label Study of Datopotamab Deruxtecan (Dato-DXd) in Combination with Pembrolizumab with or without Platinum Chemotherapy in Subjects with Advanced or Metastatic Non-Small Cell Lung Cnacer (Tropion-Lung02)


FLX475-002

Phase 1/2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination With Pembrolizumab in Advanced Cancer


NANORAY-100

A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy


OBT076-001

A Phase I, Open-label, Dose Finding Study to Assess the Safety, Tolerability, PK, and Preliminary Efficacy of OBT076, a CD205-directed ADC, in Recurrent and/or Metastatic CD205+ Solid Tumors and CD205+ HER2-negative Metastatic Breast Cancer


P1719-SUR-Z11

A Phase 2, Open-label, Multicenter, Study of an Immunotherapeutic Treatment, DPX-Survivac in Combination With Low Dose Cyclophosphamide and Pembrolizumab, in Subjects With Selected Advanced and Recurrent Solid Tumours


RGX-104-001

A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients With Advanced Solid Malignancies and Lymphoma With an Expansion in Select Malignancies


For more information, please call Research Coordinator at (505) 913-8965 or (505) 913-8935.